Nagpur
08043694597
+919730316395

Buy Glycomet-GP 2 Tablet PR - GlobMedIndia to South Africa - Botswana, Lesotho, Mozambique, Namibia.

Glycomet-GP 2 Glimepiride (2mg) + Metformin (500mg) Tablet PR – Trusted Exporter, Wholesaler & Global Supplier from India | GlobMedIndia Glycomet-GP 2 Glimepiride (2mg) + Metformin (500mg) Tablet PR Glycomet-GP 2 Tablet PR is a dual-combination antidiabetic medicine containing Glimepiride 2mg and Metformin 500mg in a prolonged-release (PR) formulation. It is widely prescribed for the management of Type 2 Diabetes Mellitus in patients requiring effective and sustained blood glucose control. This combination works by increasing insulin secretion, improving insulin sensitivity, and reducing glucose production in the liver. The prolonged-release formulation ensures steady drug absorption, better glycemic control throughout the day, and improved patient adherence. GlobMedIndia – The Medicine Exporter is a trusted international pharmaceutical supplier providing fast, safe, and secure worldwide doorstep delivery of medicines. We specialize in exporting life-saving and critical care medicines, including anti-cancer drugs, targeted therapies, injectables, and specialty pharmaceuticals across global markets. We ensure authentic, high-quality, and temperature-controlled pharmaceutical delivery directly from India to patients, hospitals, and healthcare providers worldwide. Contact Details WhatsApp: +91 9730316395 Phone: +91 9730316395 Email: info@globmedindia.com Website: https://globmedsindia.com About Glycomet-GP 2 Tablet PR Glycomet-GP 2 combines two effective antidiabetic agents: Glimepiride 2mg – Stimulates insulin release from pancreatic beta cells. Metformin 500mg – Reduces hepatic glucose production and improves insulin sensitivity. The Prolonged Release (PR) technology ensures consistent blood glucose control with reduced dosing frequency and improved tolerance. Uses of Glycomet-GP 2 Tablet PR Type 2 Diabetes Mellitus management Blood sugar control Insulin resistance treatment Long-term diabetes care Fasting and post-meal glucose control Prevention of diabetes-related complications Benefits of Glycomet-GP 2 Tablet PR Dual-action diabetes management Stable and sustained glucose control Improved insulin sensitivity Reduced risk of sugar spikes Better gastrointestinal tolerance Convenient prolonged-release formulation Why Choose GlobMedIndia? GlobMedIndia is a leading pharmaceutical exporter, wholesaler, retailer, and supplier serving hospitals, pharmacies, distributors, and healthcare institutions worldwide. Our Advantages Genuine pharmaceutical products Competitive wholesale pricing Bulk supply capability Worldwide export services Secure and compliant packaging Temperature-controlled logistics (as required) Fast international shipping Export documentation support Reliable global distribution network Export Markets – Southern Africa We export Glycomet-GP 2 Tablet PR to major healthcare markets including: South Africa Botswana Lesotho Mozambique Namibia Swaziland (Eswatini) Zimbabwe Africa region-wide supply network Trusted Glycomet-GP 2 exporter from India to South Africa Wholesale supplier of Glimepiride Metformin tablets in Johannesburg Reliable diabetes medicine exporter to Cape Town hospitals Glycomet-GP 2 distributor for healthcare providers in Pretoria Affordable Type 2 diabetes medicines from India to Africa Bulk diabetes medicine supplier for Namibia and Botswana Pharmaceutical exporter of antidiabetic medicines to Zimbabwe International supplier of prolonged-release diabetes tablets Global exporter of Glimepiride Metformin combination tablets Trusted pharmaceutical supplier for African healthcare markets Order Glycomet-GP 2 Tablet PR from GlobMedIndia GlobMedIndia is committed to delivering authentic, high-quality pharmaceutical products worldwide. Whether you are a distributor, importer, pharmacy chain, hospital, or healthcare provider, we provide dependable pharmaceutical export solutions tailored to your needs. Contact us today for wholesale inquiries, bulk orders, distributor partnerships, and global medicine export services.
 2026-06-05T10:31:30

Keywords